期刊文献+

中药补肾调冲方治疗卵巢早衰的临床研究 被引量:34

Chinical Study of Bushen Tiaochong Recipe on Treating Premature Ovarian Failure
在线阅读 下载PDF
导出
摘要 目的:观察中药补肾调冲方治疗卵巢早衰的临床疗效。方法:将60例卵巢早衰患者随机分为2组。治疗组采用补肾调冲方口服,对照组采用激素替代疗法。结果:补肾调冲方不仅可使卵巢早衰患者恢复月经周期,其月经的期、量、色、质恢复正常或基本恢复正常,类围绝经期症状消失或减轻,而且可使患者的性激素水平恢复正常,中药治疗组与西药对照组相比其疗效具有等效性,药物不良反应中药组明显低于西药组,其差异有统计学意义(P<0.05)。提示:补肾调冲方具有调节卵巢功能,治疗卵巢早衰的功效,且无明显毒副作用。 Objective: To observe the therapeutic effect of Bushen Tiaochong Recipe, a Chinese medicine,on treating the patients with premature ovarian failure (POF). Methods: 60 cases with POF were divided into two groups,i, e. the Chinese medicine group and the western medicine group( the control). The former was given orally BSTCR and the latter was given hormone replacement therapy(HRT). Results: The clinical research showed that BSTCR can regulate the menstrual cycle, duration, blood volume, colour and property as well as relieve climacteric - like symptoms, such as tidal fever, sweating, dysphoria, parethesis of skin, etc. Otherwise, BSTCR also can recover the level of gonadal hormone, Compared with HRT, BSTCR has equivalent therapeutic effect with less drug adverse reaction( P 〈 0.05 ). Conclusion : BSTCR has the effect of regulating ovarian function and curing POF without marked adverse reaction.
出处 《辽宁中医杂志》 CAS 北大核心 2007年第11期1557-1560,共4页 Liaoning Journal of Traditional Chinese Medicine
关键词 卵巢早衰 中医药疗法 补肾调冲方 激素替代疗法 premature ovarian failure hormone replacement therapy Bushen Tiaochong Recipe TCM therapeutics
作者简介 高慧(1955-),女,湖南益阳人,教授、主任医师,博士,研究方向:卵巢功能失调性疾病,盆腔炎,不孕症。
  • 相关文献

参考文献6

  • 1徐苓,宋亦军.卵巢早衰的临床表现和诊断标准[J].实用妇产科杂志,2003,19(4):195-196. 被引量:280
  • 2Laml T,Schulz- Lobmeyr I,Obruca A,et al. Premature ovarian failure:etiology an prospects[J]. Gynecol Endocrinol,2000,14:292 -302
  • 3曹泽毅.中华妇产科学[M].北京:人民卫生出版社,1999.2129.
  • 4中华人民共和国卫生部.中药新药治疗闭经的临床研究指导原则[S].北京:人民卫生出版社,1993:241-245
  • 5马良坤,林守清.卵巢早衰与卵巢不敏感综合征[J].实用妇产科杂志,2003,19(4):198-200. 被引量:98
  • 6刘梅芳 杨荔凡 何爱梅.倍美力配合中药治疗卵巢早衰28例.福建医学,2000,22(5):83-83.

二级参考文献8

  • 1Laml T, Schulz- Lobmeyr I, Obruca A, et al. Premature ovarian failure:etiology and prospects. Gynecol Endocrinol,2000 Aug, 14:292-302.
  • 2Kim TJ, Anasti JN, Flack MR, et al. Routine endocrine acreening for patients with karyotypically normal spontaneous premature ovarian failure. Obstet Gynecol, 1997,89:777-779.
  • 3Kalantaridou SN, Davis SR, Nelson LM. Premature ovarian failure. Endocrinology and Metabolism Clinics of North America, 1998,27:989-1006.
  • 4Nelson LM, Anasti .IN, Kimaey LM, et al. Development of luteinized graafian follicles in patients with karyotypically normal spontaneous premature ovarian failure. J Clin Endocrinol Metab, 1994,79:1470-1475.
  • 5Anasti JN, Kalantaridou SN, Kimzey LM, et al. Bone loss in young women with karyotypically normal spontaneous premature ovarian failure. Obstet Gynecol, 1998,91 : 12-15.
  • 6Novosad JA, Kalantaridou SN, Tong ZB, et al. Ovarian antibodies as detected by indirect immunofluorescence are unreliable in the diagnosis of autoimmune premature ovarian failure: a controlled evaluation. BMC Womens Health,2003,3: 2.
  • 7Van Kasteren YM, Schoemaker J. Premature ovarian failure: a systematic review on therapeutic interventions to restore ovarian function and achieve pregnancy. Hum-Reprod-Update, 1999 Sep-Oct,5(5) : 483-492.
  • 8Arici A, Matalliotakis IM, Koumantakis GE et al. Diagnostic role of inhibin B in resistant ovary syndrome associated with secondary amenorrhea. Fertil Steril,2002, 78(6): 1324-6.

共引文献3579

同被引文献384

引证文献34

二级引证文献318

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部